FDA Rejects Injectable Zyprexa

The U.S. Food and Drug Administration refused to approve a request by Eli Lilly and Co. to approve a long action injectable version of the schizophrenia drug Zyprexa. The FDA was concerned that injecting the drug could case dangerous excessive sedation. Zyprexa and a related drug Seroquel which is made by Astra Zeneca are both the subject of many injury lawsuits on behalf of consumers who developed diabetes. The manufacturers of Zyprexa and Seroquel downplayed the risk of diabetes to increase sales of these very profitable drugs. Many Zyprexa and Seroquel users are at greater risk of diabetes due to their mental challenges and Eli Lilly and Astra Zeneca knew of this predisposition.